We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+27.57%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$651M
AUM Growth
+$39.7M
Cap. Flow
+$2.37M
Cap. Flow %
0.36%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ZY
Zymergen Inc. Common Stock
ZY
+$2.37M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.26%
2 Materials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTX icon
1
BioNTech
BNTX
$22.8B
$233M 35.8%
1,038,674
– –
CVAC
2
DELISTED
CureVac
CVAC
$230M 35.34%
3,134,780
– –
VIR icon
3
Vir Biotechnology
VIR
$1.49B
$131M 20.13%
2,777,777
– –
IMCR icon
4
Immunocore
IMCR
$1.78B
$23M 3.53%
576,923
– –
BFLY icon
5
Butterfly Network
BFLY
$1.75B
$15M 2.3%
1,011,003
– –
BCEL
6
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$12M 1.84%
1,396,644
– –
AMRS
7
DELISTED
Amyris Inc.
AMRS
$4.8M 0.74%
292,398
– –
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
$2M 0.31%
+59,970
New +$2.37M

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q2 2021 Portfolio in Review

As of Q2 2021, Gates Foundation held 8 positions worth $651M, up 6.5% from $611M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation's Q2 2021 filing shows 1 new position. Its largest new stake was Zymergen Inc. Common Stock: 59,970 shares worth $2M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Materials.

  • Gates Foundation's largest Q2 2021 buy was Zymergen Inc. Common Stock: 59,970 shares worth $2M.
  • Gates Foundation's ten largest holdings make up 100% of its $651M portfolio in Q2 2021.
  • Gates Foundation opened 1 new position and closed 0 in Q2 2021.
  • Gates Foundation's portfolio value rose 6.5% quarter-over-quarter to $651M.

Based on Gates Foundation's 13F filing for Q2 2021, filed 13 Aug 2021.